Patients may require: New compression garments Modified treatment plans Updated self-management strategies Watch for Loose-Fitting Compression Garments Compression garments that fit appropriately at the beginning of treatment may become ineffective after substantial weight loss
Despite the link between hair loss and GLP-1 use, the rate of alopecia in patients using the drug remains fairly low, with about 3 to 9 per 1,000 medication users per year, according to the study
A recent Epic Research study found 56% of patients can maintain weight loss, or continue losing weight, one year after discontinuing the medicine
Food Sensitivity Panels Our Food Sensitivity Panels are easy to understand and helpful for anyone who thinks certain foods might be causing them health issues
Zepbound requires a BMI of 30 or a BMI of at least 27 plus another weight-related ailment
Adoption is expected to improve as oral formulations reduce injection concerns among patients starting long-term therapy
